NCT04520126View on ClinicalTrials.gov

Effect of Olivomed (Olive Extract) on Endothelial, Cardiac and Vascular Function

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

April 10, 2025

Study Completion Date

August 1, 2026

Conditions
Coronary Artery Disease
Interventions
DIETARY_SUPPLEMENT

Olivomed (capsules containing hydroxytyrosol)

patients with stable coronary artery disease will be randomised to Olivomed or placebo for one month and then they will be crossed over to the alternate treatment for one month.

DIETARY_SUPPLEMENT

OlivomedSmart - Capsules containing - combination of Oleuropein (OL), Hydroxytyrosol (HT), Oleocanthal (OC) - (OL:HT:OC 2:1:3), (5 mg HT bid).

patients with stable coronary artery disease will be randomised to combination of OL, HT, OC or placebo for one month and then they will be crossed over to the alternate treatment for one month.

Trial Locations (1)

12462

RECRUITING

"Attikon University General Hospital", Athens

All Listed Sponsors
lead

University of Athens

OTHER